In Vitro and in Vivo Characterization of the Non-Peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia

Neuropsychopharmacology - United Kingdom
doi 10.1038/sj.npp.1301549
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effects of the Selective 5-Ht7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-Like Deficits in Rats

PLoS ONE
Multidisciplinary
2013English

Characterization of Apomictic Potential in Guayule (Parthenium Argentatum) in Vivo and in Vitro

Journal of the American Society for Horticultural Science
HorticultureGenetics
2002English

In Vitro and in Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2017English

Effects of a Cannabinoid Receptor 2 Selective Antagonist on the Inflammatory Reaction to Titanium Particles in Vivo and in Vitro

Journal of International Medical Research
BiochemistryMedicineCell Biology
2010English

A Cost-Utility Analysis of Amisulpride and Paliperidone in the Treatment of Schizophrenia

Heliyon
Multidisciplinary
2019English

Peroxisome Proliferator-Activated Receptor- As a Potential Therapeutic Target in the Treatment of Preeclampsia

Hypertension
Internal Medicine
2011English

In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia

American Journal of Psychiatry
PsychiatryMental Health
2003English

WITHDRAWN: Combined Calcitonin Gene-Related Peptide Receptor Antagonist, MK-8825, and Caffeine as Potential Therapeutic Target in the Nitroglycerin-Induced Rat Migraine Model (MK-8825 and Caffeine in Migraine)

Alexandria Journal of Medicine
2018English

Characterization of the in Vitro and in Vivo Properties of CFZ533, a Blocking and Non-Depleting Anti-Cd40 Monoclonal Antibody

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy